COPD clinical trials in Ohio
16 studies for COPD are looking for participants at sites in Ohio.
Cities in Ohio
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50003, Columbus
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 25, 2026 · NCT07725939Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Dayton Clinical Research- Site Number : 8400124, Dayton
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asthma & Allergy Center - Toledo- Site Number : 8400110, Toledo
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Cleveland
- Research Site, Marion
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Columbus
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Toledo Institute of Clinical Research Inc., Toledo
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Blue Ash
- Research Site, Columbus
- Research Site, Marion
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Remington-Davis Research, Columbus
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 7, 2026 · NCT07684820Multi-Center Clean Air Randomized Controlled Trial in COPD
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Jul 31, 2026 · NCT06376994PEP Buddy in Pulmonary Rehabilitation
- Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Recruiting
Ages 40 to 89 · All sexes · Updated Jul 24, 2026 · NCT07404826Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Ohio State University Medical Center - Ohio State Lung Center, Columbus
Recruiting
Ages 40 to 80 · All sexes · Updated Apr 28, 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 40 and older · All sexes · Updated Oct 30, 2025 · NCT07059637myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Cincinnati VA Medical Center, Cincinnati
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Wexner Medical Center, Columbus
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- MetroHealth, Cleveland
Recruiting
Ages 18 and older · All sexes · Updated Oct 12, 2023 · NCT05306743From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.